Chiaradonna, F., Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., et al. (2018). PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018 (pp.121-122) [10.1136/esmoopen-2018-eacr25.291].

PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis

Chiaradonna, F.
Primo
;
Ricciardiello, F.;Votta, G.;Palorini, R.;Raccagni, I.;Brunelli, L.;De Gioia, L.;Pastorelli, R.;Moresco, R. M.;
2018

abstract + poster
Cancer therapy; breast cancer,;Novel compound; PGM3; Hexosamine Pathway;
English
25th Biennial Congress of the European Association for Cancer Research - 30 June – 3 July 2018
2018
Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018
2018
2018
3
S2
121
122
none
Chiaradonna, F., Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., et al. (2018). PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018 (pp.121-122) [10.1136/esmoopen-2018-eacr25.291].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/493839
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact